T80 Complications following infusion, transfusion and therapeutic injection

Non-Billable/Non-Specific

Includes

complications following perfusion

Type 2 Excludes

bone marrow transplant rejection (T86.01)
febrile nonhemolytic transfusion reaction (R50.84)
fluid overload due to transfusion (E87.71)
posttransfusion purpura (D69.51)
transfusion associated circulatory overload (TACO) (E87.71)
transfusion (red blood cell) associated hemochromatosis (E83.111)
transfusion related acute lung injury (TRALI) (J95.84)

Codes

T80.0Air embolism following infusion, transfusion and therapeutic injection
- T80.0XXA..., initial encounter
- T80.0XXD..., subsequent encounter
- T80.0XXS..., sequela
T80.1Vascular complications following infusion, transfusion and therapeutic injection
- T80.1XXA..., initial encounter
- T80.1XXD..., subsequent encounter
- T80.1XXS..., sequela
T80.2Infections following infusion, transfusion and therapeutic injection
- T80.21Infection due to central venous catheter
  T80.211Bloodstream infection due to central venous catheter
  T80.211A..., initial encounter
  T80.211D..., subsequent encounter
  T80.211S..., sequela
  T80.212Local infection due to central venous catheter
  T80.212A..., initial encounter
  T80.212D..., subsequent encounter
  T80.212S..., sequela
  T80.218Other infection due to central venous catheter
  T80.218A..., initial encounter
  T80.218D..., subsequent encounter
  T80.218S..., sequela
  T80.219Unspecified infection due to central venous catheter
  T80.219A..., initial encounter
  T80.219D..., subsequent encounter
  T80.219S..., sequela
- T80.22Acute infection following transfusion, infusion, or injection of blood and blood products
  T80.22XA..., initial encounter
  T80.22XD..., subsequent encounter
  T80.22XS..., sequela
- T80.29Infection following other infusion, transfusion and therapeutic injection
  T80.29XA..., initial encounter
  T80.29XD..., subsequent encounter
  T80.29XS..., sequela
T80.3ABO incompatibility reaction due to transfusion of blood or blood products
- T80.30ABO incompatibility reaction due to transfusion of blood or blood products, unspecified
  T80.30XA..., initial encounter
  T80.30XD..., subsequent encounter
  T80.30XS..., sequela
- T80.31ABO incompatibility with hemolytic transfusion reaction
  T80.310ABO incompatibility with acute hemolytic transfusion reaction
  T80.310A..., initial encounter
  T80.310D..., subsequent encounter
  T80.310S..., sequela
  T80.311ABO incompatibility with delayed hemolytic transfusion reaction
  T80.311A..., initial encounter
  T80.311D..., subsequent encounter
  T80.311S..., sequela
  T80.319ABO incompatibility with hemolytic transfusion reaction, unspecified
  T80.319A..., initial encounter
  T80.319D..., subsequent encounter
  T80.319S..., sequela
- T80.39Other ABO incompatibility reaction due to transfusion of blood or blood products
  T80.39XA..., initial encounter
  T80.39XD..., subsequent encounter
  T80.39XS..., sequela
T80.4Rh incompatibility reaction due to transfusion of blood or blood products
- T80.40Rh incompatibility reaction due to transfusion of blood or blood products, unspecified
  T80.40XA..., initial encounter
  T80.40XD..., subsequent encounter
  T80.40XS..., sequela
- T80.41Rh incompatibility with hemolytic transfusion reaction
  T80.410Rh incompatibility with acute hemolytic transfusion reaction
  T80.410A..., initial encounter
  T80.410D..., subsequent encounter
  T80.410S..., sequela
  T80.411Rh incompatibility with delayed hemolytic transfusion reaction
  T80.411A..., initial encounter
  T80.411D..., subsequent encounter
  T80.411S..., sequela
  T80.419Rh incompatibility with hemolytic transfusion reaction, unspecified
  T80.419A..., initial encounter
  T80.419D..., subsequent encounter
  T80.419S..., sequela
- T80.49Other Rh incompatibility reaction due to transfusion of blood or blood products
  T80.49XA..., initial encounter
  T80.49XD..., subsequent encounter
  T80.49XS..., sequela
T80.ANon-ABO incompatibility reaction due to transfusion of blood or blood products
- T80.A0Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified
  T80.A0XA..., initial encounter
  T80.A0XD..., subsequent encounter
  T80.A0XS..., sequela
- T80.A1Non-ABO incompatibility with hemolytic transfusion reaction
  T80.A10Non-ABO incompatibility with acute hemolytic transfusion reaction
  T80.A10A..., initial encounter
  T80.A10D..., subsequent encounter
  T80.A10S..., sequela
  T80.A11Non-ABO incompatibility with delayed hemolytic transfusion reaction
  T80.A11A..., initial encounter
  T80.A11D..., subsequent encounter
  T80.A11S..., sequela
  T80.A19Non-ABO incompatibility with hemolytic transfusion reaction, unspecified
  T80.A19A..., initial encounter
  T80.A19D..., subsequent encounter
  T80.A19S..., sequela
- T80.A9Other non-ABO incompatibility reaction due to transfusion of blood or blood products
  T80.A9XA..., initial encounter
  T80.A9XD..., subsequent encounter
  T80.A9XS..., sequela
T80.5Anaphylactic reaction due to serum
- T80.51Anaphylactic reaction due to administration of blood and blood products
  T80.51XA..., initial encounter
  T80.51XD..., subsequent encounter
  T80.51XS..., sequela
- T80.52Anaphylactic reaction due to vaccination
  T80.52XA..., initial encounter
  T80.52XD..., subsequent encounter
  T80.52XS..., sequela
- T80.59Anaphylactic reaction due to other serum
  T80.59XA..., initial encounter
  T80.59XD..., subsequent encounter
  T80.59XS..., sequela
T80.6Other serum reactions
- T80.61Other serum reaction due to administration of blood and blood products
  T80.61XA..., initial encounter
  T80.61XD..., subsequent encounter
  T80.61XS..., sequela
- T80.62Other serum reaction due to vaccination
  T80.62XA..., initial encounter
  T80.62XD..., subsequent encounter
  T80.62XS..., sequela
- T80.69Other serum reaction due to other serum
  T80.69XA..., initial encounter
  T80.69XD..., subsequent encounter
  T80.69XS..., sequela
T80.8Other complications following infusion, transfusion and therapeutic injection
- T80.81Extravasation of vesicant agent
  T80.810Extravasation of vesicant antineoplastic chemotherapy
  T80.810A..., initial encounter
  T80.810D..., subsequent encounter
  T80.810S..., sequela
  T80.818Extravasation of other vesicant agent
  T80.818A..., initial encounter
  T80.818D..., subsequent encounter
  T80.818S..., sequela
- T80.82Complication of immune effector cellular therapy
  T80.82XA..., initial encounter
  T80.82XD..., subsequent encounter
  T80.82XS..., sequela
- T80.89Other complications following infusion, transfusion and therapeutic injection
  T80.89XA..., initial encounter
  T80.89XD..., subsequent encounter
  T80.89XS..., sequela
T80.9Unspecified complication following infusion, transfusion and therapeutic injection
- T80.90Unspecified complication following infusion and therapeutic injection
  T80.90XA..., initial encounter
  T80.90XD..., subsequent encounter
  T80.90XS..., sequela
- T80.91Hemolytic transfusion reaction, unspecified incompatibility
  T80.910Acute hemolytic transfusion reaction, unspecified incompatibility
  T80.910A..., initial encounter
  T80.910D..., subsequent encounter
  T80.910S..., sequela
  T80.911Delayed hemolytic transfusion reaction, unspecified incompatibility
  T80.911A..., initial encounter
  T80.911D..., subsequent encounter
  T80.911S..., sequela
  T80.919Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed
  T80.919A..., initial encounter
  T80.919D..., subsequent encounter
  T80.919S..., sequela
- T80.92Unspecified transfusion reaction
  T80.92XA..., initial encounter
  T80.92XD..., subsequent encounter
  T80.92XS..., sequela